|Articles|August 23, 2007

Should kids be tested for lipid disorders?

After studying the issue, the US Preventive Services Task Fore (USPSTF) cannot recommend for or against the routine screening for dyslipidemia in children, adolescents, and young adults (up to 20 years of age).[more]

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Later transfer linked to longer hospitalization in severe congenital heart defects

Joyce Woo, MD, on how hospital factors may influence cardiac transfer timing for newborns

ByJoyce Woo, MD, MS

July 17th 2026

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

ByAlesia McKeown, PhD

July 17th 2026

Udenafil study shows lower ELF scores in Fontan-associated liver disease

ByMorgan Ebert, Executive Editor

July 16th 2026

Later transfer linked to longer hospitalization in severe congenital heart defects

ByJoyce Woo, MD, MS

July 16th 2026

FDA accepts cefiderocol sNDA for serious gram-negative infections in children

ByMorgan Ebert, Executive Editor

July 16th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Should kids be tested for lipid disorders?

Related Content

Joyce Woo, MD, on how hospital factors may influence cardiac transfer timing for newborns

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

Udenafil study shows lower ELF scores in Fontan-associated liver disease

Later transfer linked to longer hospitalization in severe congenital heart defects

FDA accepts cefiderocol sNDA for serious gram-negative infections in children

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Cyclosporiasis in 2026: A clinical update for pediatricians

Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing

FDA accepts cefiderocol sNDA for serious gram-negative infections in children

Joyce Woo, MD, on how hospital factors may influence cardiac transfer timing for newborns

Supporting the language development of deaf and hard of hearing children: A clinical guide for pediatric providers